Xtant Medical Holdings
XTNT
28 hedge funds and large institutions have $66.1M invested in Xtant Medical Holdings in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
17% more capital invested
Capital invested by funds: $56.7M → $66.1M (+$9.38M)
4% more funds holding
Funds holding: 27 → 28 (+1)
1.67% more ownership
Funds ownership: 69.14% → 70.81% (+1.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$5.17M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$140K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$38.6K |
| 4 |
EFA
Evernest Financial Advisors
Carmel,
Indiana
|
+$26.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$20.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$11.5K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$9.62K |
| 3 |
Renaissance Technologies
New York
|
-$6.35K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.26K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$3 |
XTNT Hedge Fund Activity: Q3 2024 in Review
28 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q3 2024, worth a combined $66.1M — up 17% from $56.7M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new XTNT positions and 1 closed out — a net gain of 1 holder — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $5.17M. The largest seller was Millennium Management, cutting an estimated $11.5K.
- 28 institutional investors held Xtant Medical Holdings (XTNT) as of Q3 2024, up from 27 in Q2 2024.
- Funds reported $66.1M of Xtant Medical Holdings stock for Q3 2024, up 17% quarter-over-quarter.
- 2 funds opened new Xtant Medical Holdings positions in Q3 2024 and 1 closed out, a net change of +1 holder.
- The largest Xtant Medical Holdings buyer in Q3 2024 was Nantahala Capital Management, an estimated $5.17M added.
- The largest Xtant Medical Holdings seller in Q3 2024 was Millennium Management, an estimated $11.5K sold.
Based on aggregated 13F filings for Q3 2024.